期刊文献+

反义microRNA-21慢病毒表达载体的构建及对喉癌细胞的增殖抑制作用 被引量:1

Construction and identification of lentiviral vector of anti-miR-21 oligonucleotides and regulation on proliferation of laryngeal squamous cell carcinoma
下载PDF
导出
摘要 目的:克隆反义微小RNA hsa-miR-21并构建其慢病毒表达载体,观察反义寡核苷酸重组慢病毒(ASO-miR-21)对喉癌细胞增殖的调控作用。方法:针对hsa-miR-21核苷酸序列,设计并合成mir-21反义寡核苷酸,将pGCSIL-GFP Vector经双酶切后连接产生pGCSIL-GFP-miR-21慢病毒表达载体,PCR筛选阳性克隆,测序鉴定。pGC-LV-miR-21、pHelper 1.0和pHelper 2.0质粒共转染细胞293T,包装慢病毒。以293T细胞绿色荧光蛋白(green fluorescent protein,GFP)的表达水平测定病毒滴度。采用MTT法及克隆形成实验检测反义miR-21(ASO-miR-21)重组慢病毒对喉癌细胞增殖能力的影响。结果:成功构建反义hsa-miR-21的慢病毒表达载体,采用ASO-miR-21抑制喉癌细胞内高水平表达miR-21的活性后,可显著抑制喉癌细胞增殖。结论:成功构建反义miR-21的慢病毒表达载体,ASO-miR-21可以明显抑制喉癌细胞增殖。 Objective:To construct a lentiviral expression vector for antisense oligonucleotid(ASO) has-miR-21 and determine its effect on proliferation of human laryngeal carcinoma cell line.Methods: Towards the miR-21 sequences of human,design and synthesis antisense oligonucleotide miR-21.The recombinant plasmid pGCSIL-GFP-miR-21was confirmed by restriction endonuclease analysis and sequencing.293T cells were cotransfected with the recombinant lentiviral vector together with lentivirus package plasmid mix containing pGC-LV-miR-21,pHelper 1.0 and pHelper 2.0.Virus titer was measured according to the expression level of GFP.MTT assay and colony formation experiment were used to observe the inhibit on percentage of ASO-miR-21 on the proliferation of Hep-2 cells.Results: The lentivirus vector of ASO pGC-LV-miR-21 was successfully constructed and it can inhibit proliferation of Hep-2 cells.Conclusion: The lentivirus vector of ASO-miR-21 was successfully constructed and it can inhibit proliferation of laryngeal carcinoma in vitro.
出处 《现代肿瘤医学》 CAS 2012年第10期2012-2016,共5页 Journal of Modern Oncology
基金 黑龙江省博士后启动基金资助项目(NO:2009LRB06-294)
关键词 MIR-21 慢病毒 喉鳞癌 反义寡核苷酸 增殖 miR-21 lentivirus laryngeal squamous cell carcinoma antisense oligonucleotid(ASO) proliferation
  • 相关文献

参考文献13

  • 1tte L,Hannon G. MicroRNAs: small RNAs with a big role in gene regulation [ J ]. Nat Rev Genct,2004,5 (7) :522 - 531.
  • 2Zhang H, I,i Y,Lai M. The microRNA network and tumor metasta- sis [ J ]. Oncogene ,2010,29 : 937 - 948.
  • 3Tiscornia G, Singer O, Verma I. Production and purification of lentiviral vectors[ J ]. Nat Protoe,2006, 1 ( 1 ) :241 - 245.
  • 4Sena -Esteves M .Tebbets JC,Steffens S, et al. Optimized large - scale production of high titer lentivirus vector pseudotypes. [ J ] Virol Methods,2004,122 : 131 - 139.
  • 5Gabriely G, Wurdinger T, Kesari S,et al. MicroRNA -21 promotes glioma invasion by targeting matrix metalloprotelnase regulators [J]. Mol CellBiol,2008,28(17): 5369 -5380.
  • 6Chan J, Kr chevsky A, Kosik K,et al. MicroRNA - 21 is an anti- apoptotic factor ill hunmn glioblasloma cells [ J ]. Cancer Res, 2005,65 : 6029 - 6033.
  • 7Jazag A, ljichi H, Kanai F, et al. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor - beta [ J ]. Onco- gene,2005,24 (4) : 662 - 671.
  • 8Sumimoto H,Kawakami Y. Lentiviral vector- mediated RNAi and its use for cancer research [J]. Future Onc01,2007,3(6) : 655 - 664.
  • 9Sun BS,Dong QZ, Ye QH, et al. Lenliviral - medialed miRNA against osteopontin suppresses tumor growth and melaslasis of hu- man hepalocellular carcinoma [J]. ftepatology,2008.48 : 1834 - 1840.
  • 10Cockrell A,Kafri T. Gene delivery by lentivirus vectors[J]. Mol Biotechno1,2007,36 ( 3 ) : 184 - 204.

同被引文献6

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部